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INTRODUCTION
In terms of their geographic scope, the dengue viruses rival malaria as the most
widespread human mosquito-borne infection of the modern era. Because they are trans-
mitted in cities and in densely populated areas, annual dengue virus infection rates are
probably several times higher than those for malaria. In terms of total number of infec-
tions, total number of sick persons and total numbers of deaths, dengue is by far the most
important human mosquito-borne viral pathogen. Further, dengue viruses are moving ;
they and their efficient mosquito vector, Aedes aegypti, have spread thousands of miles into
new territories within the past decade. But, something much more sinister is afoot.
Dengueviruses are emerging slowly, steadily as new and awesomehumanpathogens. All
this inexorable spread and mysterious change finds modern societies unprepared and
modern science in a state of disorder. The victories in this global invasion all belong to
the microorganism.
Dengue : Epidemiological Challenges
I will ask my entomological colleagues to discuss strategies for the containment of
the present dengue pandemic. Here, I will-discuss the epidemiological challenges posed by
the dengue viruses and their mid-20th century clinical outcome, dengue hemorrhagic fever,
dengue shock syndrome (DHF/DSS). I will focus on two sets of global data which
document first, the spread of Aedes aegypti and dengue, and, somewhat more interestingly,
the spread of DHF/DSS, and second, the variations in the incidence rates, the case fatality
rates and other features in the epidemiology of DHF/DSS.
Figure 1 illustrates the remarkable control achieved by the American region's Aedes
aegypti eradication campaigns by around 1960. Aedes aegypti had almost disappeared from
a whole continent and except for a small dengue 3 epidemic in Puerto Rico, dengue and
urban yellow fever were absent. Within three decades, the picture changed dramatically,
with Aedes aegypti regaining most of its pre-1930 domain. But, because the population of
Latin America has increased markedly since the end of World War II, many more persons
are at risk to dengue infections than was the case in the first half of this century.
Figure 2 contrasts dengue viral transmission in the 1960's with that of the 1990's.
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The situation on dengue transmission in Africa in the 1960's was not well known.
Evidence of the transmission of dengue types 1 and 2 in the 1960's was obtained by a
Rockefeller Foundation research group at Ibaden, Nigeria (1). But, they obtained little
information about clinical disease. DHF/DSS, which was first recognized in the 1950's, by
the end of the decade of the 1960's had been clinically or virologically documented in all the
larger Southeast Asian countries. By the 1990's, DHF/DSS was highly endemic in all
Southeast Asian countries. Epidemics had occurred on Hainan Island, and possibly in
















Fig. 1. Distribution of Aedes aegypti and dengue in the Americas, 1950-1990
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Islands, Sri Lanka and India. DHF/DSS also made the gigantic leap to the Western
Hemisphere where there were sharp outbreaks in Cuba in 1981, Venezuela in 1990 and Rio
de Janeiro in 1991. Classical DHF/DSS was documented on Tahiti in 1991-92.
Table 1 summarizes global data annually for the period 1981-1992 and in aggregate
for the period 1956-1980. Data are given for each country which has reported DHF/DSS
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Fig. 2. Global dengue epidemiology
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T able 1. Dengue hemorrhagic fever cases reported to World Health Organization regional officers, 1956
-1990. 10/6/93
YEAR PHILIPPINES VIETNAM CHINA THAILAND LAOS KAMPUCHEA MYANMAR MALAYSIA
C D C D C D C D C D C D C D C D
1956-1980 25831 2124 325409 6268 36256 2455 236556 5926 37 0 30267 1342 4862 330
1981 123 8 35323 408 25641 194 0 0 1524 90 270 14
1982 305 31 39806 361 22250 159 0 0 49 860 36
1983 1684 130 149519 1798 85293 3032 30022 231 54 6 2856 83 215 10
1984 2545 89 30498 368 69597 451 22 14 2323 39 150 5
1985 2096 210 45107 399 80076 542 1759 15 2666 134 112 ll
1986 687 30 46266 511 27837 236 365 43 2192 111 310 9
1987 859 27 354517 1566 174285 1007 5263 91 7292 222 304 9
1988 2922 68 85160 826 51510 1259 26926 179 1212 27 1181 65 233 3
1989 305 14 40205 289 37996 907 69204 280 n.a. n.a. 1196 52 517 16
1990 588 27 37569 255 38062 2626 92005 14 60 3 7241 403 6318 182 645 21
1991 1865 94630 403 43782 119 249 7 1882 148 8055 305 741 39
1992 51040 271 36485 113 4800 172 1514 40 649 25
1981-1985 6753 468 300253 3334 85293 3032 227586 1577 1835 35 9369 395 16070 76
1986-1990 5361 166 563717 3447 127568 4792 390257 1716 6900 199 7241 403 18179 632 2009 58
1991-1992 1865 - 145670 674 - - 80267 232 249 7 6682 320 9569 345 1390 64
TOTALS: 39810 2758 1335049 13723 249117 10279 934666 9451 9021 241 13923 723 67384 2714 24331 528
either to the regional offices of the World Health Organization, to the Dengue Newsletter
or to the published literature. But, what is the authenticity of these reports and what do
they mean?
V alidity of Epidemiologic Data
Regarding authenticity, we are up against some stark facts. Despite the existence
of a formal reporting system supplemented by an informal communications network, (e. g.,
the Dengue Newsletter of the South East Asia Regional Office of the World Health
Organization, New Delhi, and the Dengue Surveillance Summary published by the Dengue
Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control, USA),
reporting of DHF/DSS is both deficient and inaccurate. This is probably partly due to the
fact that DHF/DSS is a "new" disease in some areas and not as clinically recognizable as
cholera, for example. It also reflects serious deficiencies in outbreak investigation capa-
141
Table 1. page 2
I I PACIFIC
YEAR SINGAPORE INDONESIA INDIA SRILANKA CUBA VENEZUELA ISLANDS
C D C D C D C D C D C D C D
1956-1980 5240 51 48982 2676 1500 156 79 17
1981 133 0 5978 231 116143 159
1982 216 0 5451 255
1983 205 2 13668 491
1984 86 0 12710 382
1985 126 2 13588 460
1986 354 1 16529 608
1987 436 2 23864 1105
1988 245 0 47573 1527 128 28 10 0
1989 944 2 10362 464 104 21 203 20 2665 40 213* 5*
1990 1733 3 22807 821 1121 61 3325 30 2421 19
1991 2179 6 21120 578 970 31 590 6
1992 13348 382 595 20
1981-1985 766 4 51395 1819 116143 159
1986-1990 3712 8 121135 4525 232 28 1334 81 5990 70 2634 24
1991-1992 2179 6 34468 960 595 49 970 31 590 6
TOTALS: 11897 69 255980 9980 2327 233 2383 129 116143 159 5990 70 3224 30
CASES : 3,071,245 * French Polynesia
DEATHS : 51,087 10/6/93
bilities, but, most importantly, the absence in many countries of sufficient or any dengue
diagnostic laboratories. In short, DHF/DSS may not be recognized clinically, may not be
reported or investigated or may not be identified etiologically. Each of these phenomena
can contribute to underreporting. The most egregious examples are recent epidemics in
India, where the incidence may be underestimated by tens or hundreds of thousands of
cases.
But, DHF/DSS is also over-reported. The magnitude of over reporting is unknown.
For example, sometime in the early 1980's the Division of Epidemiology of the Ministry of
Public Health of Thailand began to count as notifiable cases of DHF/DSS, children who
were only seen in out-patient facilities, but never hospitalized. In the Western Pacific
Region, dengue fever and DHF/DSS are reported interchangeably. The dengue fever
syndrome may occur in the absence of DHF/DSS, and where DHF/DSS is endemic, 50-200
dengue infections may accompany a single case of DHF/DSS (2). For these reasons, the
mixed reporting of DF and DHF/DSS almost surely under-reports DF and says little about
the relative magnitude of severe dengue as a clinical or epidemiological problem. With
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the well-established ability of certain dengue viruses to produce serious bleeding phenom-
ena in adults who otherwise experience only the dengue fever syndrome (3), the potential
for serious over- or misdiagnosis of DHF/DSS is present. This is illustrated by the recent
experience in Singapore where a successful Aedes aegypti control program had reduced
dengue virus transmission significantly. The result was a cohort of young adults who are
susceptible to dengue infection (4). From many studies we know that in adults, the ratio
of clinical diseases to dengue infection is nearly one. With a sensitive surveillance system,
this means that a few thousand dengue infections can produce a few thousand clinical cases
of dengue fever. If some of these cases express bleeding phenomena, an "outbreak"of
DHF may be diagnosed. This may explain at least some of the recent emergence of
"DHF/DSS" in Singapore under conditions of very low endemicity.
There are many reasons why disease reporting should be accurate, for example, the
planning and evaluation of control programs require complete and accurate disease inci-
dence or prevalence data. But, with DHF/DSS, the most serious outcome of poor report-
ing may be to hopelessly confuse an epidemiological understanding of DHF/DSS.
Granting the caveat that at present DHF/DSS may be both under- and over-report-
ed, what do the available data mean?
Significance of epidemiologic data : research question
So far as is known, DHF/DSS occurs only in the context of sequential infections or
with the infection of infants circulating maternal dengue antibodies. Antibody-dependent
infection enhancement still appears to be the central pathogenic mechanism which trans-
forms the relatively benign dengue fever syndrome to the rapid-onset leaky capillary
syndrome knownas DHF/DSS. It is important to underscore that dengue infections with
moderate or severe gastrointestinal hemorrhaging, even with fatal outcome may not be
DHF/DSS. Good data suggest that dengue infections in individuals with underlying
pathology, such as a peptic ulcer, may cause severe bleeding phenomena (3). This causes
a background of DHF/DSS-like cases which occurs everywhere that dengue fever occurs.
Strain variations may account for some of the inhomogeneities in "hemorrhagic dengue."
A glance at Figure 2 reveals certain unexplained phenomena - the absence until
recently of DHF/DSS in India ; this, despite the circulation of multiple dengue serotypes (2,
5). The absence of DHF/DSS from much of the Caribbean and Latin America despite the
circulation of multiple serotypes and the absence of DHF/DSS from Africa despite the
circulation of multiple dengue serotypes.
These seemingly similar phenomena may have different underlying mechanisms.
Genetic studies of dengue viruses associated with secondary infection DHF/DSS in Cuba,
Venezuela and Brazil have shown these viruses to be Southeast Asian topotypes (6). An
extremely important opportunity presented itself to make similar studies on viruses
recovered from the newly emerged DHF/DSS of India and Sri Lanka. To date, these
important studies have not been done ; and, it is not as clear as it could be that DHF/DSS
is associated with a Southeast Asian "biotype."
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Even more unfortunate has been the failure to test the Kliks hypothesis in India. In
a longitudinal study in Thailand, Kliks et al. (7), observed that essentially all children who
circulated enhancing antibodies in the absence of low levels of cross-reactive neutralizing
antibodies were hospitalized during secondary dengue infections. This simple but power-
ful study should have been repeated in India where pre-outbreak monotypic dengue
-immunesera could have been examined for low level neutralizing antibodies against the
dengue strains recovered from the DHF/DSS outbreak. This test may be the most
important predictor of risk of acquiring DHF/DSS during a secondary dengue infection.
It might also help describe the different sets of viral epitopes which might be present on the
sequential infecting virus pairs responsible for either enhanced or down-regulated secon-
dary infections.
Data from the Cuban DHF/DSS outbreak suggest a remarkable, possibly unique, but
certainly important phenomenon -a humandengue resistance gene found in blacks (8). It
maybe relevant that DHF/DSS has not been reported from Africa ; even dengue fever
outbreaks have been reported infrequently.
Table 1 shows quite clearly the yearly variations observed in reported DHF/DSS
cases over the past 12 years. Despite many claims to the contrary, no regular periodicity
can be detected. Countries which are immediately adjacent to each other, Myanmar,
Thailand, Laos and Vietnam were all involved simultaneously in the gigantic 1987 epi-
demic. Remarkably, Malaysia and Singapore seem not to have participated in the 1987
epidemic at all. By contrast, the 1987 epidemic arrived in 1988 in the island nations of
Southeast Asia, the Philippines and Indonesia. Or so it seems.
But, the only available data on the 1987 outbreak are from Thailand and fragmen-
tary data from Indonesia which showed unusual dengue 3 activity to be present in 1987 and
1988, respectively (9, 10). Otherwise, we know little about the virological events of 1987
and less about the antecedent events which may have been critical in determining 1987
DHF/DSS attack rates.
Of some interest in this connection are the studies of Lam and his group in Malaysia
(10) who, in the relatively low incidence year of 1989, observed that dengue 1 viruses
predominated in dengue fever cases, while in 1990 and 1991, years with relatively high
deaths, dengue 2 virus isolations were prominent. These data are reminiscent of the 1980
Thailand experience where, on a background of dengue 1 infections, secondary dengue 2
caused DHF/DSS (ll).
But, what about the mysterious extremely low incidence of DHF/DSS in the
Philippines? Comparative age-specific hospitalization rates are shown in Table 2. It has
been suggested that the transition from Aedes aegypti to Aedes albopictus has never been
completed in the Philippines as it was on mainland Southeast Asia. Albopictus is a vastly
inferior transmission vector of dengue viruses. The fact is, we don't know why dengue
disease is still such a small problem in the Philippines. No one has bothered to ask the
question let alone find an answer.
A final mystery can be found in case fatality rates. Data for Thailand, Myanmar
144
Table2．Average yearly DHF／DSS age－SpeCific hospitalization rates for
Children＜1r14years－01d，infive Southeast Asian countries，1986
－1990．
C O U N T R Y A V E R A G E A N N U A L D H F ／D S S
H O S P ．R A T E S ，P E R lOO，000
P h ilip plneS 4 ．5 ．
V ietn am 448 ．9
T ha ilan d 429 ．0
M y an m ar 25 ．2
Ind on esia 63 ．1
Table3．DHFcases，deathsandcase⊥fatalityratesinIndonesia，MyanmarandThailand，
1986－1992
Y E A R IN D O N E S IA M Y A N M A R T H A IL A N D
N O．O F N O iO F C F R N O ．O F N O．O F C F R N O ．O F N O．O F C F R
C A S E S DE A T H S ％ C A S E S DE A T H S ％ C A S E S DEA T H S ％
1986 16，529 608 3 i65 2，192 111 5．06 27，837 236 0．84
1987 23，864 1，105 4．56 7，292 222 3．04 174，285 1，007 0．58
1988 47，573 1，527 3．20 1，181 65 5．50 26，926 179 0．66
1989 10，362 464 4．50 1■，196 52 5．78 69，204 280 0．40
1990 22，807 821 3．60 6，318 182 2．8 92，005 414 0．45
1991 21，120 578 2．7 8，055 305 3．70 43，782 119 0．29















In this paper, I have noted that important genetic questions are posed by dengue.
Understanding how the severity of secondary dengue infections may be controlled by
humangenes could shed light on viral pathogenetic mechanisms generally. A still larger
challenge is to understand the viral mechanisms which operate to cause DHF/DSS. Is
DHF/DSS the result simply of the sequential circulation of two dengue viruses which do
not share neutralizing epitopes? Is this the secret of the Southeast Asian dengue
topotypes which appear to cause epidemic DHF/DSS? Why do secondary dengue 1
infections not result in DHF/DSS? Or do they? What accounts for epidemic-specific
severity differences reflected by varying case fatality rates?
It is doubtful that the answers to these questions can emerge from the fragmented
and weak surveillance and research resources committed to dengue research at present. It
is critically important that the global dengue epidemiological picture be monitored and that
sufficient resources are committed to take advantage of novel twists in epidemiological
expression of dengue infection. The introduction of DHF/DSS into India, for example,
should never have gone unnoticed and unstudied. Affiliated with a regional or global
surveillance mechanism should be several high quality prospective country studies, each
designed so as to measure dengue infection in an open population of at-risk children.
These studies should specifically test the hypothesis that children circulating enhancing but
not neutralizing antibodies after their first dengue infection are at risk to DHF/DSS with
dengue 2, 3 or 4 infections. The matching virus pairs should be studied appropriately.
Ordinarily, the world would turn to WHO to provide regional leadership and funding for
the research and control of public health problems. The time has cometo admit candidly
that other mechanisms and other funding must be found.
What seems hopelessly complicated in biology has often been found to be explained
by simple underlying mechanisms. The DHF/DSS global pandemic has struck at a time
whenbiomedical research possesses unique power and precise tools. Is it too much to ask
that an appropriate allocation of research resources be committed to save the lives of
children.
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